Rheumatoid arthritis

Familial risk of seropositive rheumatoid arthritis and interaction with smoking: a population-based cohort study

Rheumatology (Oxford)Published Population-based cohort study

Main finding · Seropositive RAResult — go to the resultHazard ratio 4.52 95% CI 3.98–5.12

Authors' conclusion

Our findings indicate the possibility of an interaction between RA-associated genes and smoking.

Study context

Population
Individuals with first-degree relatives (FDRs), 2002–2018, National Health Insurance and Health Screening Program databases
Participants
5,524,403 individuals
Exposure
Individuals with affected FDRs vs individuals with unaffected FDRs
Outcome
Seropositive RA (familial risk)
Methodological detailsNational Health Insurance and Health Screening Program databases, additive interaction (RERI)
  • National Health Insurance and Health Screening Program databases
  • Additive interaction (RERI)

Main finding

Seropositive RA

Hazard ratio

4.52

95% CI 3.98–5.12

Affected FDRvs Unaffected FDR
HR 4.52 (95% CI 3.98–5.12)

As reported in the abstract

Observational data: associations, not effects.

Further findings

Smoking and risk of seropositive rheumatoid arthritis (RA), by intensity

HR (95% CI)
Heavy smoking1.92 (1.70–2.18)
Moderate smoking1.15 (1.04–1.28)

Additive interaction between smoking and family history (RERI)

Combined effect of smoking and family history higher than the sum of their individual effects, statistically non-significant: RERI
1.30 (95% CI −0.92, 3.51)
Heavy smokers with a positive family history: RERI
4.13 (95% CI −0.88, 9.13)
Moderate smokers with a positive family history: RERI
0.61 (95% CI −1.90, 3.13)
  • Suggesting a dose-response interaction pattern

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Familial risk of seropositive rheumatoid arthritis and interaction with smoking: a population-based cohort study. Rheumatology (Oxford). Published 24 January 2023. doi:10.1093/rheumatology/kead048

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.